semaglutide 2 mg/1.5ml Ozempic® (semaglutide) GLP-1 RA for Type Diabetes Semaglutide Injectable – 2 mg/mL

MMW - Fortschritte der Medizin 163 , 5761 (2021)

Especially now, in the era of innovative therapies, analyses are available indicating that intensive lipid-lowering therapy, especially combination therapy with the use of PCSK9 inhibitors, may translate into a highly significant reduction in the risk of patients with multibed disease, and the more advanced the disease (more beds involved), the greater the benefits

L-carnitine may be considered after that, not instead of that

[2] [7] These findings led regulatory authorities, including the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA), to include specific warnings and precautions in the prescribing information for all GLP-1 medications